Niagen Bioscience (NAGE) Cash from operations

annual CFO:

$12.11M+$4.99M(+70.14%)
December 1, 2024

Summary

  • As of today (June 17, 2025), NAGE annual cash flow from operations is $12.11 million, with the most recent change of +$4.99 million (+70.14%) on December 1, 2024.
  • During the last 3 years, NAGE annual CFO has risen by +$36.27 million (+150.11%).
  • NAGE annual CFO is now at all-time high.

Performance

NAGE Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

quarterly CFO:

$7.88M-$700.00K(-8.16%)
March 1, 2025

Summary

  • As of today (June 17, 2025), NAGE quarterly cash flow from operations is $7.88 million, with the most recent change of -$700.00 thousand (-8.16%) on March 1, 2025.
  • Over the past year, NAGE quarterly CFO has increased by +$7.59 million (+2572.20%).
  • NAGE quarterly CFO is now -8.16% below its all-time high of $8.58 million, reached on December 1, 2024.

Performance

NAGE quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

TTM CFO:

$19.70M+$7.59M(+62.66%)
March 1, 2025

Summary

  • As of today (June 17, 2025), NAGE TTM cash flow from operations is $19.70 million, with the most recent change of +$7.59 million (+62.66%) on March 1, 2025.
  • Over the past year, NAGE TTM CFO has increased by +$15.08 million (+326.34%).
  • NAGE TTM CFO is now at all-time high.

Performance

NAGE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NAGE Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+70.1%+2572.2%+326.3%
3 y3 years+150.1%+209.5%+175.9%
5 y5 years+159.2%+251.0%+230.0%

NAGE Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+150.1%-8.2%+305.7%at high+190.0%
5 y5-yearat high+150.1%-8.2%+199.8%at high+175.9%
alltimeall timeat high+150.1%-8.2%+187.4%at high+175.9%

NAGE Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$7.88M(-8.2%)
$19.70M(+62.7%)
Dec 2024
$12.11M(+70.1%)
$8.58M(+145.6%)
$12.11M(+190.0%)
Sep 2024
-
$3.50M(-1423.9%)
$4.17M(+288.0%)
Jun 2024
-
-$264.00K(-189.5%)
$1.08M(-76.7%)
Mar 2024
-
$295.00K(-54.5%)
$4.62M(-35.1%)
Dec 2023
$7.12M(-147.1%)
$649.00K(+63.9%)
$7.12M(+15.9%)
Sep 2023
-
$396.00K(-87.9%)
$6.14M(+206.4%)
Jun 2023
-
$3.28M(+17.5%)
$2.00M(-139.2%)
Mar 2023
-
$2.79M(-951.2%)
-$5.11M(-66.2%)
Dec 2022
-$15.10M(-37.5%)
-$328.00K(-91.2%)
-$15.10M(-23.4%)
Sep 2022
-
-$3.74M(-2.4%)
-$19.71M(-10.0%)
Jun 2022
-
-$3.83M(-46.8%)
-$21.89M(-15.7%)
Mar 2022
-
-$7.20M(+45.6%)
-$25.96M(+7.4%)
Dec 2021
-$24.16M(+128.0%)
-$4.94M(-16.5%)
-$24.16M(+25.9%)
Sep 2021
-
-$5.92M(-25.0%)
-$19.20M(+12.1%)
Jun 2021
-
-$7.89M(+46.1%)
-$17.12M(+58.8%)
Mar 2021
-
-$5.41M(<-9900.0%)
-$10.78M(+1.7%)
Dec 2020
-$10.60M(-48.1%)
$22.00K(-100.6%)
-$10.60M(-5.6%)
Sep 2020
-
-$3.85M(+147.1%)
-$11.23M(-25.8%)
Jun 2020
-
-$1.56M(-70.2%)
-$15.15M(-33.0%)
Mar 2020
-
-$5.22M(+755.9%)
-$22.61M(+10.6%)
Dec 2019
-$20.44M(-2.2%)
-$610.00K(-92.1%)
-$20.44M(-18.1%)
Sep 2019
-
-$7.76M(-14.0%)
-$24.96M(+11.3%)
Jun 2019
-
-$9.02M(+196.0%)
-$22.44M(+12.4%)
Mar 2019
-
-$3.05M(-40.7%)
-$19.97M(-4.5%)
Dec 2018
-$20.91M(+113.3%)
-$5.14M(-1.9%)
-$20.91M(+7.0%)
Sep 2018
-
-$5.24M(-20.1%)
-$19.54M(+32.2%)
Jun 2018
-
-$6.55M(+64.2%)
-$14.78M(+7.5%)
Mar 2018
-
-$3.99M(+5.9%)
-$13.74M(+40.2%)
Dec 2017
-$9.80M(+233.9%)
-$3.77M(+693.1%)
-$9.80M(+67.7%)
Sep 2017
-
-$475.00K(-91.4%)
-$5.85M(+6.1%)
Jun 2017
-
-$5.51M(>+9900.0%)
-$5.51M(+5923.2%)
Mar 2017
-
-$51.00K(-126.7%)
-$91.50K(-96.9%)
Dec 2016
-$2.94M
$191.20K(-236.2%)
-$2.94M(-26.2%)
Sep 2016
-
-$140.40K(+53.8%)
-$3.98M(-13.5%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$91.30K(-96.8%)
-$4.60M(+4.2%)
Mar 2016
-
-$2.90M(+239.3%)
-$4.42M(+109.2%)
Dec 2015
-$2.11M(-18.2%)
-$853.60K(+12.3%)
-$2.11M(+40.4%)
Sep 2015
-
-$760.40K(-909.8%)
-$1.50M(+33.1%)
Jun 2015
-
$93.90K(-115.9%)
-$1.13M(-36.1%)
Mar 2015
-
-$591.10K(+140.6%)
-$1.77M(-31.5%)
Dec 2014
-$2.58M(-33.9%)
-$245.70K(-36.4%)
-$2.58M(-36.6%)
Sep 2014
-
-$386.50K(-28.9%)
-$4.07M(+7.9%)
Jun 2014
-
-$543.40K(-61.3%)
-$3.77M(-18.2%)
Mar 2014
-
-$1.40M(-18.9%)
-$4.61M(+17.9%)
Dec 2013
-$3.91M(-61.4%)
-$1.73M(+1889.4%)
-$3.91M(+33.6%)
Sep 2013
-
-$87.10K(-93.7%)
-$2.92M(-24.2%)
Jun 2013
-
-$1.38M(+95.6%)
-$3.85M(-37.5%)
Mar 2013
-
-$705.80K(-5.9%)
-$6.17M(-39.0%)
Dec 2012
-$10.12M(+146.9%)
-$749.80K(-26.4%)
-$10.12M(-7.8%)
Sep 2012
-
-$1.02M(-72.4%)
-$10.97M(-3.7%)
Jun 2012
-
-$3.70M(-20.6%)
-$11.39M(+26.5%)
Mar 2012
-
-$4.66M(+190.8%)
-$9.00M(+119.6%)
Dec 2011
-$4.10M(+54.0%)
-$1.60M(+11.4%)
-$4.10M(+22.5%)
Sep 2011
-
-$1.44M(+10.0%)
-$3.34M(+48.6%)
Jun 2011
-
-$1.31M(-628.7%)
-$2.25M(-12.7%)
Mar 2011
-
$247.30K(-129.2%)
-$2.58M(-3.1%)
Dec 2010
-$2.66M(+571.8%)
-$846.80K(+146.2%)
-$2.66M(+58.3%)
Sep 2010
-
-$343.90K(-79.0%)
-$1.68M(+19.3%)
Jun 2010
-
-$1.63M(-1096.3%)
-$1.41M(-7440.1%)
Mar 2010
-
$164.10K(+22.8%)
$19.20K(-104.8%)
Dec 2009
-$396.20K(-79.4%)
$133.60K(-285.3%)
-$396.20K(-25.2%)
Sep 2009
-
-$72.10K(-65.1%)
-$529.80K(+15.8%)
Jun 2009
-
-$206.40K(-17.9%)
-$457.70K(+82.1%)
Mar 2009
-
-$251.30K(<-9900.0%)
-$251.30K(+870.3%)
Dec 2008
-$1.92M(+4890.6%)
-
-
Feb 2008
-
$0.00(-100.0%)
-$25.90K(-32.7%)
Nov 2007
-$38.50K
-$3600.00(-16.3%)
-$38.50K(+10.3%)
Aug 2007
-
-$4300.00(-76.1%)
-$34.90K(+14.1%)
May 2007
-
-$18.00K(+42.9%)
-$30.60K(+142.9%)
Feb 2007
-
-$12.60K
-$12.60K

FAQ

  • What is Niagen Bioscience annual cash flow from operations?
  • What is the all time high annual CFO for Niagen Bioscience?
  • What is Niagen Bioscience annual CFO year-on-year change?
  • What is Niagen Bioscience quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Niagen Bioscience?
  • What is Niagen Bioscience quarterly CFO year-on-year change?
  • What is Niagen Bioscience TTM cash flow from operations?
  • What is the all time high TTM CFO for Niagen Bioscience?
  • What is Niagen Bioscience TTM CFO year-on-year change?

What is Niagen Bioscience annual cash flow from operations?

The current annual CFO of NAGE is $12.11M

What is the all time high annual CFO for Niagen Bioscience?

Niagen Bioscience all-time high annual cash flow from operations is $12.11M

What is Niagen Bioscience annual CFO year-on-year change?

Over the past year, NAGE annual cash flow from operations has changed by +$4.99M (+70.14%)

What is Niagen Bioscience quarterly cash flow from operations?

The current quarterly CFO of NAGE is $7.88M

What is the all time high quarterly CFO for Niagen Bioscience?

Niagen Bioscience all-time high quarterly cash flow from operations is $8.58M

What is Niagen Bioscience quarterly CFO year-on-year change?

Over the past year, NAGE quarterly cash flow from operations has changed by +$7.59M (+2572.20%)

What is Niagen Bioscience TTM cash flow from operations?

The current TTM CFO of NAGE is $19.70M

What is the all time high TTM CFO for Niagen Bioscience?

Niagen Bioscience all-time high TTM cash flow from operations is $19.70M

What is Niagen Bioscience TTM CFO year-on-year change?

Over the past year, NAGE TTM cash flow from operations has changed by +$15.08M (+326.34%)
On this page